Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Molecular Targeted Agents for Hepatocellular Carcinoma: Current Status and Future Perspectives — Masatoshi Kudo (2016) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Molecular Targeted Agents for Hepatocellular Carcinoma: Current Status and Future Perspectives
Shared by
Masatoshi Kudo
Molecular Targeted Agents for Hepatocellular Carcinoma: Current Status and Future Perspectives
Editorial Material
2016
en
Authors
Masatoshi Kudo
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2023
[Management of hepatocellular carcinoma: current status and future perspective].
Masatoshi Kudo
Editorial Material
2019
Combination Cancer Immunotherapy with Molecular Targeted Agents/Anti-CTLA-4 Antibody for Hepatocellular Carcinoma
Masatoshi Kudo
Article
2003
Hepatocellular carcinoma: present status and future prospects
Josep M. Llovet
,
Michel Beaugrand
Journal of Hepatology
Article
2008
Molecular targeted therapies in hepatocellular carcinoma
Josep M. Llovet
,
Jordi Bruix
Hepatology
Article
2021
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives
Monica Margoni
,
Paolo Preziosa
,
Massimo Filippi
,
Maria A. Rocca
Discussion(0)
No comments yet. Be the first to comment.